MedPath

The effect of chitosan supplementation in patients with nonalcoholic fatty liver disease

Not Applicable
Conditions
onalcoholic fatty liver.
Fatty (change of) liver, not elsewhere classified
Registration Number
IRCT20180412039284N2
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Aged between 18-65 years (both genders)
Diagnosis of nonalcoholic fatty liver disease by ultrasound
Willingness to participate
No allergies to seafood

Exclusion Criteria

Suffering from viral hepatitis, liver cirrhosis, Wilson's disease, acute fatty liver, hepatocellular carcinoma, hypothyroidism, lipodystrophy, diseases that involves bile ducts
History of chronic liver disease
History of significant weight loss (more than 10% of body weight during 6 months ago) or weight loss surgery
History of antioxidant supplementation, omega 3 and milk thistle during 6 months ago
History of liver damaging drugs
History of cardiovascular
History of renal disease
Alcohol consumption more than 20 gram per day
Pregnancy
Lactation
Menopause
Energy consumption less than 800 or more than 4200 kilocalorie per day

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath